- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 8, 2025 | 13.21M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2025 | $0 |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $180K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $120.27M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $109.16M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $626.77M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $572.26M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $804.13M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $745.98M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 13.04M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $1.19M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $1.76M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $162.48M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $155.06M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.25 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.26 |
| Net Income | Q1 2025 · Mar 31, 2024 | $3.32M |